Joyner J. David 4
4 · CVS HEALTH Corp · Filed Dec 3, 2024
Insider Transaction Report
Form 4
Joyner J. David
DirectorPresident and CEO
Transactions
- Award
Premium Stock Option
2024-11-30$71.82/sh+1,492,537$107,194,007→ 1,492,537 totalExercise: $71.82From: 2025-11-30Exp: 2031-11-30→ Common Stock (1,492,537 underlying)
Holdings
- 44,241
Common Stock (Restricted)
- 51,959
Stock Option
Exercise: $74.31From: 2024-04-01Exp: 2033-04-01→ Common Stock (51,959 underlying) - 40,681
Common Stock
Footnotes (2)
- [F1]Option became exercisable in four equal annual installments, commencing 4/1/2024.
- [F2]Option becomes exercisable in three equal annual installments, commencing 11/30/2025.